SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-146508
Filing Date
2024-05-24
Accepted
2024-05-24 07:00:27
Documents
11
Period of Report
2024-05-24

Document Format Files

Seq Description Document Type Size
1 6-K d824271d6k.htm 6-K 12311
2 EX-99.1 d824271dex991.htm EX-99.1 64708
3 EX-99.2 d824271dex992.htm EX-99.2 26994
4 EX-99.3 d824271dex993.htm EX-99.3 5601
5 EX-99.4 d824271dex994.htm EX-99.4 9616
6 GRAPHIC g824271dsp022.jpg GRAPHIC 119620
7 GRAPHIC g824271dsp023.jpg GRAPHIC 109838
8 GRAPHIC g824271g0524023209786.jpg GRAPHIC 2924
9 GRAPHIC g824271ng58k65.jpg GRAPHIC 10111
10 GRAPHIC g824271page25.jpg GRAPHIC 10429
11 GRAPHIC g824271page6.jpg GRAPHIC 9630
  Complete submission text file 0001193125-24-146508.txt   457814
Mailing Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW 44 (0)20 8154 4600
Achilles Therapeutics plc (Filer) CIK: 0001830749 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40299 | Film No.: 24980781
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)